The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …

The therapeutic potential of sotrovimab in the treatment of coronavirus disease 2019 (COVID‐
19) is a controversial issue. The aim of this study was to evaluate the efficacy and safety of …

We read with great interest that monoclonal antibody (mAb) cocktail may serve as an
effective and targeted therapeutic strategy in the treatment of patients with COVID-19. 1 …

Aims This study aimed to evaluate the efficacy and safety of regdanvimab, an anti‐SARS‐
COV‐2 monoclonal antibody approved by the European Medicines Agency in November …

Introduction: The casirivimab and imdevimab antibody cocktail has proven to be extremely
effective against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta …

Background & Aims: Monoclonal antibodies cazirivimab and imdevimab are used as a
combination drug in the treatment of severe acute respiratory syndrome coronavirus-2 …

Introdução: A terapia de anticorpos monoclonais Casirivimabe-imdevimabe é uma
importante ferramenta no manejo do COVID-19, projetada para se ligar à proteína spike do …

Background: Monoclonal antibody therapy is one of the most promising treatments for
COVID-19 infection. Casirivimab-imdevimab is a monoclonal antibody cocktail which is …

Numerous therapeutic and prophylactic interventions are tried being developed and tried for
COVID-19, from repurposed drugs, antivirals to immunotherapy including convalescent …

ABSTRACT Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-
CoV-2 virus which causes respiratory illness. Monoclonal antibodies have been widely used …